Content area
Full text
LATEST COMPANY NEWS
News and Commentary
Australian biotech takes a new route to treating Alzheimer's - 9/5/2017
An Australian biotech company is launching a novel attack on Alzheimer's disease.
For the complete story see:
http://www.afr.com/lifestyle/health/mens-health/australian-biotech-takes-a-new-route-to-treating-alzheimers-20170506-gvzk57
The Australian - Biotechs ready to fight loss of R&D tax break - 8/5/2017
MTP sector was on alert on expectations Scott second federal budget would include changes to the research and development tax incentive.
For the complete story see:
http://www.theaustralian.com.au/business/companies/biotechs-ready-to-fight-loss-of-rd-tax-break/news-story/f11d7512b09385d00a10ee4e887b032d
Australian Life Scientist - Australian researchers find unexpected genomic landscape in melanoma - 5/5/2017
Genetic changes in acral and mucosal melanomas are completely different to the mutations found in skin melanoma.
For the complete story see:
http://www.labonline.com.au/content/life-scientist/news/australian-researchers-find-unexpected-genomic-landscape-in-melanoma-595984568
Australian Life Scientist - Genomics alliance receives first round of funding - 5/5/2017
QGHA has received funding for nine research projects as part of a $25 million initiative of the Palaszczuk government.
For the complete story see:
http://www.labonline.com.au/content/life-scientist/news/genomics-alliance-receives-first-round-of-funding-1479347650
The West Australian - Medical cannabis to be grown in WA - 5/5/2017
Australian drug regulators have granted what is believed to be the first licence to grow medical cannabis in WA.
For the complete story see:
https://thewest.com.au/news/wa/all-clear-to-grow-medical-cannabis-ng-b88465432z
Proactive Investors Australia - AusCann Group Holdings wins medical cannabis licence - 5/5/2017
AusCann will join an exclusive group of medical cannabis companies after having been granted a licence to cultivate medicinal cannabis in Australia.
For the complete story see:
http://www.proactiveinvestors.com.au/companies/news/177343/auscann-group-holdings-wins-medical-cannabis-licence-177343.html
PACE Today - Australian-made artificial intelligence for pharmaceuticals - 4/5/2017
AI will be used to help data-driven sales and decision-making in the pharmaceutical industry.
For the complete story see:
https://pacetoday.com.au/australian-artificial-intelligence/
http://www.macrosourcemedia.com/store/p11/Internet_of_Things_Market_Report_%2843_pages%29_-_December_2016.html
Media Releases
IDT Australia Limited (ASX: IDT) - ANI Pharmaceuticals Launches IDT Australia's Pindolol Tablets In the U.S. - 9/5/2017
9 May 2017, Melbourne - IDT Australia Limited (ASX: IDT) issues the following market update: ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the U.S. launch of Pindolol Tablets, 5mg and 10mg, which is used in the treatment of hypertension. The annual U.S. market for Pindolol Tablets is approximately $10 million, per IMS Health.
This U.S. product launch signals the successful culmination of IDT Australia's efforts to re-launch the first of its acquired generic drug products; and follows-on from IDT's earlier announcement (ASX:IDT 27 April 2017) regarding the U.S. Food and Drug Administration's clearance...